Podcast: Scaling Up Your Business
You may also be interested in...
Download this Special Report, written by Mike Ward, Chief Content Officer for Informa Pharma Intelligence Insights Portfolio, to learn how growing a life science business involves big decisions and formidable challenges the world over. The discussion, among several c-suite executives from a number of companies, focuses on how access to the right kind of capital, scientific and business talent, and a supportive political and regulatory environment are all important factors for achieving ambitions.
Gilead's remdesivir is first drug fully approved by FDA to treat COVID-19. Roche and Atea team up on an investigational direct acting antiviral while Moderna reaches the 30,000-patient enrollment target for its Phase III COVE study of the company's investigational mRNA vaccine.
Diffusion Pharmaceuticals and WPD Pharmaceuticals get new chief medical officers.